---
title: "Mr David Parker — Ownership Dossier"
canonical: https://whiteintel.dev/entity/c7e4e017-b47b-538e-8915-4e8b488bca09
json: https://whiteintel.dev/api/public/dossier/c7e4e017-b47b-538e-8915-4e8b488bca09
identifier: oo-person:GB-COH-PER-07942228-wTJtu-_xkLzDT3tHhbmQK9aZh3M
jurisdiction: GB
risk: Low
source: WhiteIntel corporate-ownership graph
---

# Mr David Parker

**Type:** Person  
**Jurisdiction:** GB  
**Identifier:** `oo-person:GB-COH-PER-07942228-wTJtu-_xkLzDT3tHhbmQK9aZh3M`  
**Risk level:** Low  
**Canonical dossier:** https://whiteintel.dev/entity/c7e4e017-b47b-538e-8915-4e8b488bca09  
**Structured JSON / MCP:** https://whiteintel.dev/api/public/dossier/c7e4e017-b47b-538e-8915-4e8b488bca09  

## Ownership & control

### Holdings / subsidiaries

- **YAPTON PHARMACY LIMITED** (beneficial owner) — 50% — https://whiteintel.dev/entity/1f1cd347-34b1-5a10-a900-38f60223a124

## Provenance

- OpenOwnership — https://www.openownership.org

---

_This is the markdown-for-agents view of the WhiteIntel dossier for **Mr David Parker**. Human view: https://whiteintel.dev/entity/c7e4e017-b47b-538e-8915-4e8b488bca09 · Structured JSON: https://whiteintel.dev/api/public/dossier/c7e4e017-b47b-538e-8915-4e8b488bca09._

_Risk levels are heuristic investigative leads, not legal determinations of beneficial ownership. Every claim carries a source; an absent edge means "not yet observed in current sources", not "does not exist"._